2024
|
Invention
|
Il-18 polypeptides and uses thereof. Provided herein are IL- 18 polypeptide variants that have bi... |
|
Invention
|
Inducible il-18 prodrugs. Provided herein are IL- 18 polypeptide prodrugs comprising IL- 18, a ha... |
|
Invention
|
Anti-cd28 antibodies and methods related thereto. inter aliavivo vivo methods, and manufacturing ... |
|
Invention
|
Antibody libraries.
The present invention overcomes the inadequacies inherent in the known metho... |
|
Invention
|
Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus... |
2023
|
Invention
|
Anti-activin a/b antibodies and uses thereof. Provided herein are antibody agents that bind speci... |
|
Invention
|
Ph-dependent anti-cd3 antibodies and methods relating thereto. vivo vivo methods, screening metho... |
|
Invention
|
Rationally designed, synthetic antibody libraries and uses therefor.
The present invention overc... |
|
Invention
|
Anti-coagulation factor xi antibodies. Antibodies that bind the apple 3 domain of human coagulati... |
|
Invention
|
Myeloproliferative conditions.
Provided herein are antibody agents that bind specifically to Act... |
|
Invention
|
Myeloproliferative conditions. Provided herein are antibody agents that bind specifically to Acti... |
2022
|
Invention
|
Targeting gdf15-gfral pathway. Provided herein are methods of treating and/or preventing certain ... |
|
Invention
|
Anti-idiotype antibodies.
The present disclosure relates to anti-idiotypic antibodies binding to... |
|
Invention
|
Anti-idiotype antibodies. The present disclosure relates to anti-idiotypic antibodies binding to ... |
|
Invention
|
Anti-cd3-binding domains and antibodies comprising them, and methods for their generation and use... |
|
Invention
|
Systems and methods for intelligent construction of antibody libraries.
Presented herein are sys... |
|
Invention
|
Systems and methods for intelligent construction of antibody libraries. Presented herein are syst... |
|
Invention
|
Anti-activin a antibodies, compositions and uses thereof. Provided herein are antibody agents tha... |
|
Invention
|
Anti-cd3 antibodies.
The present disclosure includes anti-CD3 binding domains and antibodies and... |
|
Invention
|
Anti-cd3 antibodies. The present disclosure includes anti-CD3 binding domains and antibodies and/... |
|
Invention
|
Anti-respiratory syncytial virus antibodies, and methods of their generation and use. Anti-RSV an... |
|
Invention
|
Anti-gdf15 antibodies, compositions and uses thereof.
Provided herein are antibody agents that b... |
|
Invention
|
Anti-gdf15 antibodies, compositions and uses thereof. Provided herein are antibody agents that bi... |
|
Invention
|
Monoclonal antibodies and cocktails for treatment of ebola infections. Described herein are compo... |
|
Invention
|
Fc variants with reduced effector function.
The present invention provides Fc variants and polyp... |
|
Invention
|
Polyclonal mixtures of antibodies, and methods of making and using them. A method of broadening e... |
|
Invention
|
Ltbp complex-specific inhibitors of tgfβ and uses thereof. Disclosed herein are inhibitors, such ... |
|
Invention
|
Variant ch3 domains engineered for preferential ch3 heterodimerization, multi-specific antibodies... |
|
Invention
|
Variant ch1 domains and variant cl domains engineered for preferential chain pairing and multi-sp... |
2021
|
Invention
|
Anti-crimean-congo hemorrhagic fever virus antibodies, and methods of their generation and use.
... |
2020
|
Invention
|
Antibodies against bace1 and use thereof for neural disease immunotherapy. The invention provides... |
|
Invention
|
Polyspecificity reagents, methods for their preparation and use. The present invention relates, i... |
|
Invention
|
Antibody libraries. The present invention overcomes the inadequacies inherent in the known method... |
|
Invention
|
Ch1 domain variants engineered for preferential light chain pairing and multispecific antibodies ... |
|
Invention
|
High affinity anti-cd3 antibodies, and methods for their generation and use.
Antibodies and anti... |
|
Invention
|
Engineered ph-dependent anti-cd3 antibodies, and methods for their generation and use.
Engineere... |
2014
|
G/S
|
Antibodies for commercial use, namely, for medical diagnostic and therapeutic use; biochemicals i... |
|
G/S
|
Antibodies for commercial use, namely, for medical diagnostic and therapeutic use; antibodies for... |
2011
|
G/S
|
Antibodies for commercial use, namely, for industrial,
scientific or research use. Antibodies fo... |
2008
|
G/S
|
Biochemical preparations, namely antibodies for commercial
use, specifically for industrial, sci... |
2007
|
G/S
|
Antibodies for commercial use, namely, for industrial, scientific or research use |
|
G/S
|
Scientific research and development, namely, development of antibodies for others |
|
G/S
|
Custom antibody production and generation; custom manufacture of antibodies for others |
|
G/S
|
Antibodies for commercial use, namely, for medical diagnostic and therapeutic use |